TIMELESS deficiency sensitizes thyroid cancer to cisplatin treatment via the DNA damage repair pathway
Abstract DNA damage repair (DDR) pathway was activated in thyroid cancer under cisplatin treatment. TIMELESS, a circadian rhythm gene, was…
DNA damage repair (DDR)
A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer
Abstract DNA damage repair (DDR) is critical in maintaining normal cellular function and genome integrity and is associated with cancer…
JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
Abstract Background: JMJD8 has recently been identified as a cancer-related gene, but current studies provide limited information. We aimed to…
The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies
Abstract Background: Protein kinase membrane associated tyrosine/threonine 1 (PKMYT1) regulates cell cycle and is a part of DNA damage repair…